5 of the best ASX shares to buy in February

Adore Beauty Group Limited (ASX:ABY) and Appen Ltd (ASX:APX) are two of five ASX shares to buy in February. Here’s why…
The post 5 of the best ASX shares to buy in February appeared first on The Motley Fool Australia. –

ASX shares to buy in February

With a new month upon us, now could be a good time to look if there are any additions that could take your portfolio to the next level.

But which ASX shares should you buy? Here are five that are rated as buys:

Adore Beauty Group Limited (ASX: ABY)

Adore Beauty is Australia’s number one pureplay online beauty retailer with almost 600,000 active customers. It currently has an estimated ~$11 billion a year opportunity in the Australian beauty and personal market, which is materially more than the revenue of $158.2 million it expects to generate in 2020. This gives it a long runway for growth over the 2020s. Morgan Stanley currently has an overweight rating and $8.35 price target on the company’s shares.

Altium Limited (ASX: ALU)

Altium is a printed circuit board (PCB) design software provider. It is a leading player in the electronic design industry and is now aiming to take things to the next level by dominating it. The key to this is its cloud-based Altium 365 product, which management expects to help it achieve its target of doubling its subscriber numbers to 100,000 and increasing its revenue by ~150% to US$500 million by 2026. Credit Suisse is positive on the company and has an outperform rating and $35.00 price target on its shares.

Appen Ltd (ASX: APX)

Appen is a leading developer of high-quality, human annotated datasets for machine learning and artificial intelligence (AI). It has a team of one million+ contractors preparing the data for the models of some of the largest tech companies. Demand has softened this year because of the pandemic, but management is confident it will rebound once the crisis passes. Macquarie has an outperform rating and $27.00 price target on its shares.

CSL Limited (ASX: CSL)

CSL is one of the world’s leading biotechnology companies. It is home to CSL Behring, the global number one player in the plasma therapies industry, and Seqirus, which is the number two player in the global influenza vaccines industry. Its shares have come under pressure in FY 2021 due to concerns about plasma collection headwinds (these are a vital ingredient in many of its therapies). However, analysts at UBS believe this is a buying opportunity and have recently put a buy rating and $346.00 price target on its shares.

Pushpay Holdings Group Ltd (ASX: PPH)

Pushpay is a donor management and community engagement platform provider with a focus on the faith sector. In FY 2020 the company reported a 32% increase in operating revenue to US$129.8 million. Management is expecting similarly strong growth again in FY 2021. The good news is that this is still only a fraction of its long term target. Management is aiming to win a 50% share of the medium to large US church market, which is estimated to be a US$1 billion revenue opportunity. Goldman Sachs is a fan of Pushpay and has a conviction buy rating and $2.59 price target on its shares.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of June 30th

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Altium. The Motley Fool Australia owns shares of and has recommended PUSHPAY FPO NZX. The Motley Fool Australia owns shares of Altium and Appen Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 5 of the best ASX shares to buy in February appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!